3,430$
-1,15%
Echtzeit-Aktienkurs Clover Health Investments Corp.
Bid:
Ask:
Echtzeit-Chart der Clover Health Investments Corp. Aktie
Börsenkurse Clover Health Investments Corp.
| gettex | - | - | - | - | 3,019€ | 0,40% |
| Börse Stuttgart | - | - | - | - | 3,019€ | 1,65% |
| Echtzeit USD | - | - | - | - | 3,433$ | 0,09% |
| Echtzeit Euro | - | - | - | - | 3,019€ | 0,77% |
| USA | - | - | - | - | 3,430$ | -1,15% |
| Nasdaq | - | - | - | - | 3,420$ | -1,44% |
| Lang & Schwarz | - | - | - | - | 3,019€ | 0,62% |
Fundamentaldaten der Clover Health Investments Corp. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [USD] | 1,37 Mrd. | -46,27 Mio. | -43,01 Mio. | -0,09 | - | - | 1,21 |
| 2023 [USD] | 2,03 Mrd. | -213,36 Mio. | -213,36 Mio. | -0,44 | - | - | 0,81 |
| 2022 [USD] | 3,49 Mrd. | -338,84 Mio. | -338,84 Mio. | -0,71 | - | - | 0,47 |
| 2021 [USD] | 1,54 Mrd. | -587,76 Mio. | -587,76 Mio. | -1,42 | - | - | 1,05 |
| 2020 [USD] | 0,12 Mio. | - | -6,74 Mio. | -0,05 | - | - | 3027,63 |
| 2019 [USD] | - | -0,02 Mio. | -0,02 Mio. | 0,00 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Clover Health Investments Corp. Aktie
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.